Yarrow Bioscience (YARW) reported a net loss of $9.7 million, or $0.43 per basic and diluted share, for the third quarter ended September 30, 2026. Research and development expenses were $5.3 million, while general and administrative expenses totaled $5.5 million.
The company reported $268.9 million in cash and cash equivalents at quarter-end and said it expects available cash to fund operations into 2030. Enrollment is ongoing in the Phase 2a portion of the DIRECTION-GD trial of YB-101 in Graves’ disease.
- Third-quarter net loss was $9.7 million; nine-month net loss was $19.0 million.
- Cash and cash equivalents totaled $268.9 million as of September 30, 2026.
- Yarrow completed an approximately $172.5 million underwritten public offering in September 2026.
- Phase 2a topline results for YB-101 are expected in the second half of 2027.
- The company completed its merger with VYNE Therapeutics in July 2026 and began trading under the YARW ticker.
$VYNE Hedge Fund Activity
We have seen 14 institutional investors add shares of $VYNE stock to their portfolio, and 23 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ADAR1 CAPITAL MANAGEMENT, LLC added 1,886,101 shares (+177.3%) to their portfolio in Q2 2026, for an estimated $61,364,296
- BRAIDWELL LP added 916,077 shares (+inf%) to their portfolio in Q2 2026, for an estimated $29,804,565
- KVP CAPITAL ADVISORS, LP removed 490,540 shares (-98.0%) from their portfolio in Q2 2026, for an estimated $15,959,718
- IKARIAN CAPITAL, LLC added 259,614 shares (+4900.2%) to their portfolio in Q2 2026, for an estimated $8,446,541
- SHAY CAPITAL LLC removed 153,591 shares (-9.5%) from their portfolio in Q2 2026, for an estimated $4,997,083
- BOOTHBAY FUND MANAGEMENT, LLC removed 81,371 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $2,647,405
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 61,173 shares (+105.9%) to their portfolio in Q2 2026, for an estimated $1,990,263
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
